In one paragraphArticle in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Hidetomo KobayashiLaboratory of Molecular Microbiological Science, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima, Japan.ORCID 0000-0002-5918-4268 Soshi SeikeLaboratory of Molecular Microbiological Science, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima, Japan.ORCID 0000-0001-9029-0715 Eizo TakahashiLaboratory of Medical Microbiology, Department of Health Pharmacy, Yokohama University of Pharmacy, Yokohama, Kanagawa, Japan.
Keinosuke OkamotoCollaborative Research Center of Okayama University for Infectious Diseases in India, National Institute of Cholera Enteric Diseases, Kolkata, India.
Hiroyasu YamanakaLaboratory of Molecular Microbiological Science, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima, Japan.ORCID 0000-0002-4012-9672 Funding
Hiroshima International University Special Research Grant Program for Research Projects Pursuing Novel Developments TK2506865Japan Society for the Promotion of Science JP16K18926Japan Society for the Promotion of Science JP20K07504
6 · The paper itselfAbstract
Indexed as
Aeromonas veroniiBacterial ToxinsEpithelial Cell Adhesion MoleculeEpithelial CellsPore Forming Cytotoxic ProteinsSerine ProteasesAeromonasCell LineHumansIntestinal Barrier FunctionVirulenceaerolysinBacterial ToxinsEpithelial Cell Adhesion MoleculePore Forming Cytotoxic ProteinsSerine ProteasesaerolysinAeromonas serine protease (ASP)Aeromonas veronii biotype sobriaclaudin-7EpCAMepithelial barriertight junctiontransepithelial electrical resistance (TEER)zonula occludens
Identifiers
PMID42429552
PMCPMC13492141
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390